Genomic targeting of recombinant adeno-associated virus

Angela Huttner(University Hospital of Geneva), Hildegard Buening, Martin Hutter, Marie Stark, Anne Girod, Michael Hallek(Integrated Oncology (United States)), Susanne Schnittger(Goethe University Frankfurt), Christian Plank, Claudia Schoch, R. Guckenberger

European Journal of Cancer

September 1, 2001

10.1016/s0959-8049(01)80448-2

Cited by 0

Related Papers

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

|Blood|2008|3.2k

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

|Blood|2018|1.7k

Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia

|New England Journal of Medicine|2014|1.7k

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

|Blood|2005|703

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

|Annals of Oncology|2015|604